1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Pulmonary Drug Delivery Devices Market
2.2. Global Pulmonary Drug Delivery Devices Market, By Technology, 2024 (US$ Million)
2.3. Global Pulmonary Drug Delivery Devices Market, By Application, 2024 (US$ Million)
2.4. Global Pulmonary Drug Delivery Devices Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024
3. Pulmonary Drug Delivery Devices Market: Competitive Analysis
3.1. Market Positioning of Key Pulmonary Drug Delivery Devices Market Vendors
3.2. Strategies Adopted by Pulmonary Drug Delivery Devices Market Vendors
4. Pulmonary Drug Delivery Devices Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Pulmonary Drug Delivery Devices Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
7. North America Pulmonary Drug Delivery Devices Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
7.3. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
7.4.Pulmonary Drug Delivery Devices Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
7.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
7.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
7.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
8. UK and European Union Pulmonary Drug Delivery Devices Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
8.3. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
8.4.Pulmonary Drug Delivery Devices Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
8.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
8.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
8.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
8.4.1.4.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
8.4.1.5.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
8.4.1.6.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
9. Asia Pacific Pulmonary Drug Delivery Devices Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
9.3. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
9.4.Pulmonary Drug Delivery Devices Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
9.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
9.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
9.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
9.4.1.4.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
9.4.1.5.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
9.4.1.6.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
10. Latin America Pulmonary Drug Delivery Devices Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
10.3. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
10.4.Pulmonary Drug Delivery Devices Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
10.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
10.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
10.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
11. Middle East and Africa Pulmonary Drug Delivery Devices Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
11.3. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
11.4.Pulmonary Drug Delivery Devices Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
11.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
11.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2023-2033, USD (Million)
11.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2023-2033, USD (Million)
12. Company Profile
12.1. Boehringer Ingelheim GmbH
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Novartis AG
12.3. GlaxoSmithKline plc
12.4. AstraZeneca plc
12.5. Teva Pharmaceutical Industries Ltd.
12.6. Merck & Co., Inc.
12.7. MannKind Corporation
12.8. F. Hoffmann-La Roche Ltd.
12.9. Bristol-Myers Squibb Company
12.10. Mylan N.V.
12.11. Omron Corporation
12.12. 3M Healthcare
12.13. Sunovion Pharmaceuticals, Inc.
12.14. Koninklijke Philips N.V.
12.15. Gerresheimer AG
12.16. Bespak
12.17. AptarGroup, Inc.
12.18. SHL Group
12.19. Nypro Healthcare Inc.
12.20. Chiesi Farmaceutici S.p.A.
12.21. Hovione